Finance

Beta
Lists
NZM2:FRA
Novozymes A/S
€49.13
-1.25%
(-0.62) 1D
Jun 3, 11:47:05 AM GMT+2  ·   EUR
All symbols
SymbolPriceChange% Change
Generating top insights for NZM2...
Open
€49.72
High
€49.72
Low
€49.13
Mkt. cap
155.14B
Avg. vol.
83.00
Volume
40.00
52-wk high
€65.38
52-wk low
€44.99
No. of employees
11K
Open
€49.72
High
€49.72
Low
€49.13
Mkt. cap
155.14B
Avg. vol.
83.00
Volume
40.00
52-wk high
€65.38
52-wk low
€44.99
No. of employees
11K
News stories
From sources across the web
Profile
Novozymes A/S was a global biotechnology company headquartered in Bagsværd, outside of Copenhagen, Denmark. The company's focus was the research, development and production of industrial enzymes, microorganisms, and biopharmaceutical ingredients. The company merged with Chr. Hansen to form Novonesis in January 2024. Prior to the merger, the company had operations around the world, including in China, India, Brazil, Argentina, United Kingdom, the United States, and Canada. Class B shares of its stock were listed on the NASDAQ OMX Nordic exchange. Wikipedia
About Novozymes A/S
CEOEster Baiget
Employees11.1K
Founded2000
Headquarters-
SectorSpeciality chemicals
Websitenovonesis.com
Previous reportsAll values in DKK
Loading Previous Earnings...
Income statement
Revenue
Net income
Revenue
Cost of goods sold
Cost of revenue
Research and development expenses
Total research and development expenses
Selling, general, and admin expenses
Operating expense
Total operating expenses
Operating income
Other non operating income
EBT including unusual items
EBT excluding unusual items
Income tax expense
Effective tax rate
Other operating expenses
Net income
Net profit margin
Earnings per share
Interest and investment income
Interest expense
Net interest expenses
Depreciation and amortization charges
EBITDA
Gain or loss from assets sale
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer

Research

AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer